[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Deng et al., 2017 - Google Patents

Dapagliflozin-citric acid cocrystal showing better solid state properties than dapagliflozin

Deng et al., 2017

Document ID
10112465528063251972
Author
Deng J
Lu T
Sun C
Chen J
Publication year
Publication venue
European Journal of Pharmaceutical Sciences

External Links

Snippet

Dapagliflozin (DAP) is a potent and selective sodium-glucose contransporter-2 inhibitor, for treating type 2 diabetes. DAP propanediol monohydrate (DAP-PDO-H 2 O, 1: 1: 1) is the solid form used in the current tablet product to address the severe hygroscopicity problem of …
Continue reading at www.sciencedirect.com (other versions)

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom

Similar Documents

Publication Publication Date Title
Deng et al. Dapagliflozin-citric acid cocrystal showing better solid state properties than dapagliflozin
Zhou et al. Resveratrol cocrystals with enhanced solubility and tabletability
Aitipamula et al. Cocrystallization with flufenamic acid: comparison of physicochemical properties of two pharmaceutical cocrystals
Lu et al. Improving solid-state properties of berberine chloride through forming a salt cocrystal with citric acid
Aitipamula et al. Novel solid forms of the anti-tuberculosis drug, Isoniazid: Ternary and polymorphic cocrystals
Huang et al. Simultaneously improving the physicochemical properties, dissolution performance, and bioavailability of apigenin and daidzein by co-crystallization with theophylline
Park et al. Emodin-nicotinamide (1: 2) cocrystal identified by thermal screening to improve emodin solubility
JP2020100624A (en) L-ornithine phenyl acetate and methods of making thereof
Vasilev et al. Novel cocrystals of itraconazole: Insights from phase diagrams, formation thermodynamics and solubility
Thakuria et al. Cocrystal dissociation under controlled humidity: a case study of caffeine–glutaric acid cocrystal polymorphs
Sevukarajan et al. Synthesis and characterization of a pharmaceutical co-crystal:(aceclofenac: nicotinamide)
Wang et al. 2: 1 5-Fluorocytosine–acesulfame CAB cocrystal and 1: 1 5-fluorocytosine–acesulfame salt hydrate with enhanced stability against hydration
CN102015696A (en) Crystal forms of 5- [3- (2, 5-dichloro-4, 6-dimethyl-1-oxy-pyridine-3-yl) [1,2,3] oxadiazol-5-yl] -3-nit robenzene-1, 2-diol
Roy et al. Mechanochemical cocrystallization to improve the physicochemical properties of chlorzoxazone
Lin et al. Mechanism study on stability enhancement of adefovir dipivoxil by cocrystallization: Degradation kinetics and structure-stability correlation
Perumalla et al. Robust bulk preparation and characterization of sulfamethazine and saccharine salt and cocrystal polymorphs
Nugrahani et al. Composing novel diclofenac potassium and l-proline salt cocrystal as a strategy to increase solubility and dissolution
Khanfar et al. Preparation and evaluation of co-amorphous formulations of telmisartan—amino acids as a potential method for solubility and dissolution enhancement
Thomas et al. Design and characterization of valsartan co-crystals to improve its aqueous solubility and dissolution behavior
Watanabe et al. Reduced deliquescency of isosorbide by cocrystallization and mechanisms for hygroscopicity
Aitipamula et al. Polymorphism and distinct physicochemical properties of the phloretin–nicotinamide cocrystal
Jia et al. Cocrystals of regorafenib with dicarboxylic acids: Synthesis, characterization and property evaluation
Liu et al. Bergenin-isonicotinamide (1: 1) cocrystal with enhanced solubility and investigation of its solubility behavior
Kong et al. Sweet pharmaceutical salts of stanozolol with enhanced solubility and physical stability
Wang et al. Solid-state characterization of 17β-estradiol co-crystals presenting improved dissolution and bioavailability